Literature DB >> 6454698

Fractionation and characterization of the immunosuppressive substance in crude extracellular products released by Streptococcus intermedius.

M P Arala-Chaves, M T Porto, P Arnaud, M J Saraiva, H Geada, C C Patrick, H H Fudenberg.   

Abstract

The noncytotoxic immunosuppressive substance detected in crude extracellular products of Streptococcus intermedius (CEP-SI) was fractionated by two steps of preparative isoelectric focusing in sucrose gradients using ampholytes of pH range from 3.5 to 6 and 4 to 5, respectively. The in vitro and in vivo suppressor effects of the most highly purified fraction of CEP-Si, designated fraction 3' (F3'EP-Si), corresponded well with those of the original CEP-Si. F3'EP-Si was sensitive to the effects of alpha, gamma, and delta chymotrypsin, trypsin, and heating. It contained approximately 1% of the total amount of protein found in the original CEP-Si, corresponding to a single band on analytical isoelectric focusing, stainable by Coomassie Blue and of isoelectric point of 4.25. The absorption spectrum of F3'EP-Si had a maximum at 260 nm but its biological activity was resistant to deoxyribonuclease and ribonuclease A and it did not contain material stainable by methylene blue. It was also resistant to neuraminidase and did not contain material stainable by periodic acid schiff. We conclude that the substance responsible for the suppressor activity of CEP-Si is a protein of molecular weight approximately 90,000, which adheres to Sephadex of cellulose acetate and forms complexes with other, nonactive constituents of CEP-Si.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6454698      PMCID: PMC370797          DOI: 10.1172/jci110247

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Isoelectric focusing in layers of granulated gels. II. Preparative isoelectric focusing.

Authors:  B J Radola
Journal:  Biochim Biophys Acta       Date:  1975-03-28

2.  Immunosuppressive properties of a ribonuclease-containing fraction from bacterial cultures.

Authors:  C B Carpenter; J D Milton; J F Mowbray; A E Butterworth
Journal:  Immunology       Date:  1972-08       Impact factor: 7.397

3.  Investigation and standardization of the conditions for micro-lymphocyte cultures.

Authors:  M G Du Bois; D R Huismans; P T Schellekens; V P Eijsvoogel
Journal:  Tissue Antigens       Date:  1973

4.  L-glutaminase: suppression of lymphocyte blastogenic responses in vitro.

Authors:  E M Hersh
Journal:  Science       Date:  1971-05-14       Impact factor: 47.728

5.  Separation of leukocytes from blood and bone marrow. Introduction.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  Immunosuppressive enzymes.

Authors:  E M Hersh
Journal:  Transplant Proc       Date:  1973-09       Impact factor: 1.066

7.  Resolution of multiple ribonucleic acid species by polyacrylamide gel electrophoresis.

Authors:  A C Peacock; C W Dingman
Journal:  Biochemistry       Date:  1967-06       Impact factor: 3.162

8.  Effects of a streptococcal lipoteichoic acid on host responses in mice.

Authors:  G A Miller; J Urban; R W Jackson
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

9.  Degradation of Escherichia coli polynucleotide phosphorylase by E. coli endogenous proteases and by trypsin.

Authors:  M N Thang; L Dondon; T Godefroy-Colburn
Journal:  Biochimie       Date:  1971       Impact factor: 4.079

10.  Activation of human B lymphocytes. I. Direct plaque-forming cell assay for the measurement of polyclonal activation and antigenic stimulation of human B lymphocytes.

Authors:  A S Fauci; K R Pratt
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

View more
  5 in total

1.  Protective effect of a T-cell-dependent immunosuppressive, B-cell-mitogenic protein (F3'EP-Si, or P90) produced by Streptococcus intermedius.

Authors:  M Lima; A Bandeira; D Portnoi; A Ribeiro; M A Chaves
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

Review 2.  Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen.

Authors:  K L Ruoff
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

3.  Immunological activities of a Candida albicans protein which plays an important role in the survival of the microorganism in the host.

Authors:  D Tavares; A Salvador; P Ferreira; M Arala-Chaves
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

4.  Strong mitogenic effect for murine B lymphocytes of an immunosuppressor substance released by Streptococcus intermedius.

Authors:  M P Arala-Chaves; A S Ribeiro; M M Santarém; A Coutinho
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

5.  Prevalence of β-hemolytic groups C and F streptococci in patients with acute pharyngitis.

Authors:  Alaa H Al-Charrakh; Jawad K T Al-Khafaji; Rana H S Al-Rubaye
Journal:  N Am J Med Sci       Date:  2011-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.